ArticleLeukemia2023
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Li Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleLeukemia2023
Li Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.